Cross-Talk Between PKA and Akt Protects Endothelial Cells From Apoptosis in the Late Ischemic Preconditioning

Author:

Bellis Alessandro1,Castaldo Diletta1,Trimarco Valentina1,Monti Maria Gaia1,Chivasso Pierpaolo1,Sadoshima Junichi1,Trimarco Bruno1,Morisco Carmine1

Affiliation:

1. From the Dipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche (A.B., D.C., M.G.M., P.C., B.T., C.M.), Dipartimento di Neuroscienze (V.T.), Università FEDERICO II, Napoli, Italy; and the Department of Cell Biology and Molecular Medicine (J.S.), New Jersey Medical School, Newark.

Abstract

Objective— The aim of this study was to explore the molecular mechanisms involved in late preconditioning-induced cell protection in endothelial cells. Methods and Results— Preconditioning (PC) was induced by exposing bovine aortic endothelial cells (BAECs) to 3 cycles of 15 minutes of hypoxia followed by 15 minutes of reoxygenation. A 12-hour period of hypoxia induced cell death in 60% of BAECs (48±5% apoptosis, 12±4% necrosis). Early and late PC decreased hypoxia-induced apoptotic (25±5% and 28±4%, respectively) and necrotic (6±3%, and 8±2%, respectively) cell death. Consistently, hypoxia-induced caspase-3 cleavage was reduced by PC. Pretreatment with H89 (protein kinase A [PKA] inhibitor), LY294002 (phosphatidyl-inositol-3-kinase [PI3K] inhibitor), and N-acetyl-cysteine (antioxidant) abrogated late PC-induced cell protection, whereas inhibition of protein kinase C by Go6983, and of nitric oxide synthesis by L-NAME,1400W and bovine eNOS siRNA did not. In addition, in early and late PC, PKA physically interacted with the phosphorylated form of Akt, suggesting that PKA is required for Akt phosphorylation. Expression of PKA and Akt dominant negative mutants inhibited ischemic late PC-induced protection, indicating that these kinases play a key role in late PC-mediated cell protection. Conclusions— Late ischemic PC protects BAECs against hypoxia through PKA- and PI3K-dependent activation of Akt.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3